Kane Biotech’s Antibiofilm Technologies Published in Two New Scientific Books (03/01/2010)
IMRIS Books First Quarter of Positive Results, Record Revenues in Q4 (02/09/2010)
Miraculins Announces Private Placement Offering (02/09/2010)
DispersinB® Patent issues in Australia (01/25/2010)
GVI Clinical Development Solutions Expands Strength in Clinical and Regulatory Strategy (01/25/2010)
Miraculins Announces Partnership with Inverness Medical Innovations to Develop a Diagnostic Test for Preeclampsia (01/07/2010)
DiaMedica proposes to expand into neurological and other disorders through acquisition of Sanomune (12/06/2009)
A Good Citizen- Biovail in Steinbach (Drug Firm Concentrates All Its Work in Manitoba) (10/28/2009)
Winnipeg Chamber of Commerce Receives Funding Boost Under the Canada-Manitoba Economic Partnership Agreement (10/27/2009)
Cangene Announces Highest-ever Financial Results for Fiscal 2009 (10/23/2009)
DispersinB® Topical Wound Gel Passes First Set of Biocompatibility Tests (10/03/2009)
Cangene Seeks H1N1 Flu Victims for Research (09/30/2009)
Get Focused - 2009 QNET Excellence Conference (09/10/2009)
Kane Biotech selected to Present at Biomedical Defence Conference in Washington, DC (08/20/2009)
DispersinB® Topical Wound Gel Manufacturing Completed (08/10/2009)
Kane Biotech Announces Amendment to Warrant Terms and Early Exercise Warrant Incentive Program (08/06/2009)
Kane Biotech Granted United States Patent for Oral Care Technology (07/21/2009)
Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society (06/30/2009)
Medicure Announces Private Placement (06/26/2009)
Miraculins Completes Agreements with Diagnostic Technologies Ltd. and CIIRDF (06/25/2009)
Ray of Hope for Cancer Patients (06/18/2009)
Cangene Sees Dramatic Revenue Growth (06/18/2009)
Miraculins Announces Closing of $400,000 Private Placement Offering (06/18/2009)
IH Systems Extends Global Reach into South Korean Medical Device Market (05/10/2009)
Miraculins Announces Private Placement Offering (04/28/2009)
Ebola Vaccine Shows Promise (03/30/2009)
Kane Biotech Announces Private Placement Offering (03/30/2009)
Scientists Learning To Target Bacteria Where They Live (03/16/2009)
MGI Pharma vet takes DiaMedica reins (02/23/2009)
Merck Frosst Releases Details on the Effectiveness of Raltegravir (02/23/2009)
Australia’s Leading Oncology Drug Compounder Chooses RIVA System (02/13/2009)
Dr. Isabella Caniggia Joins Miraculin's Scientific Advisory Board (02/13/2009)
Miraculins Announces Improved Detection of Aggressive Prostate Cancer With Combination of PSP94 and Free Over Total PSA Ratio (02/10/2009)
Kane Biotech Receives an Additional Contribution from NRC-IRAP to Develop its DispersinB® Antibiofilm Wound Gel Product (02/06/2009)
The latest issue of Medical Technology Watch Canada is now available (02/02/2009)
IH Systems announces another RIVA unit is in full operation (01/28/2009)
Miraculins’ Completed P2V™ Immunoassay Confirms Mass Spectrometry Results (01/23/2009)
Librestream's general exam camera now available under NESC (01/14/2009)
Genesys Venture Inc. Congratulates DiaMedica Inc., Kane Biotech Inc. and Sanomune Inc. (12/29/2008)
Former LSAM President Jeff Hartry (Cangene) sworn in as Chair, Winnipeg Chamber of Commerece (12/29/2008)
LSAM Recognizes Leaders in the Life Science Sector (12/29/2008)
Miraculins Announces Amendment to Private Placement Offering (10/23/2008)
CHOC Children's Draws First Patient Dose With RIVA System (10/17/2008)
Medicure Launches New Clinical Program (07/03/2008)
Acrobat Reader required to view PDFs. To download the FREE reader please click this link.
